Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medacta GroupFRA:6MD 93 FCF Yield % is 0.33 as of Jul. 17, 2026, which is 267% above its 10-year median of 0.09. GuruFocus rates FRA:6MD with a GF Score™ of 93/100 and a GF Value™ of €180.03 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Medacta Group ranks better than 55.91% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medacta Group's FCF Yield % or its related term are showing as below:
FRA:6MD'
s FCF Yield % Range Over the Past 10 Years
Min: -0.98 Med: 0.09 Max: 1.37
Current: 0.33
During the past 11 years, the highest FCF Yield % of Medacta Group was 1.37%. The lowest was -0.98%. And the median was 0.09%.
FRA:6MD's FCF Yield % is ranked better than 55.91% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.4
vs FRA:6MD: 0.33
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medacta Group FCF Yield % Related Terms
Medacta Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medacta Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medacta Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medacta Group FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medacta Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medacta Group (FRA:6MD) has a FCF Yield % of 0.33 as of Jul. 17, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medacta Group and its competitors. This is 267% above median its historical median of 0.09. According to the industry distribution chart, Medacta Group ranks #377 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 44.1%.
Is Medacta Group's FCF Yield % too high?
Medacta Group's current FCF Yield % of 0.33 is 267% above median its 10-year median of 0.09. Based on the distribution chart, Medacta Group ranks #377 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medacta Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medacta Group ranks #377 out of 855 companies for FCF Yield %. This puts Medacta Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medacta Group and its competitors. Medacta Group's current FCF Yield % is 0.33, which is 267% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Based on GuruFocus' analysis, Medacta Group (FRA:6MD) is currently considered Modestly Undervalued. The stock's GF Value™ is €180.03, compared to a current price of €146.00 — trading 18.9% below its estimated fair value. The current FCF Yield % is 0.33, which is 267% above median its 10-year median of 0.09. Medacta Group's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medacta Group (FRA:6MD), the current FCF Yield % is 0.33 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medacta Group (FRA:6MD) Overvalued in 2026?
Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued.
The current stock price of €146.00 is trading 18.9% below its estimated GF Value™ of €180.03.
GuruFocus considers Medacta Group to be Modestly Undervalued.
Key valuation signals for FRA:6MD:
FCF Yield %: 0.33 (267% above median its 10-year median of 0.09)
GF Value™: €180.03 vs. price of €146.00 (18.9% below fair value)
No single metric tells the full story. See the FRA:6MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
93GF Score
Get the complete analysis for FRA:6MD
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6MD has been successfully added to your 
